Trinity Biotech (TRIB) Interest Coverage Ratio Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 37.54% |
| Jun 30, 2024 | 28.23% |
| Mar 31, 2024 | 66.63% |
| Dec 31, 2023 | 23.33% |
| Sep 30, 2023 | 29.33% |
| Jun 30, 2023 | 35.73% |
| Mar 31, 2023 | 24.46% |
| Dec 31, 2022 | 47.44% |
| Sep 30, 2022 | 37.11% |
| Jun 30, 2022 | 16.46% |
| Mar 31, 2022 | 15.87% |
| Dec 31, 2021 | 17.86% |
| Sep 30, 2021 | 2.48% |
| Jun 30, 2021 | 39.60% |
| Mar 31, 2021 | -10.48% |
| Dec 31, 2020 | -22.98% |
| Sep 30, 2020 | -22.25% |
| Jun 30, 2020 | 30.74% |
| Mar 31, 2020 | 62.31% |
| Dec 31, 2019 | 60.83% |
| Sep 30, 2019 | 67.71% |
| Jun 30, 2019 | 60.74% |
| Mar 31, 2019 | 65.75% |
| Sep 30, 2018 | 64.55% |
| Jun 30, 2018 | 59.74% |
| Mar 31, 2018 | 59.87% |
| Dec 31, 2017 | 66.72% |
| Sep 30, 2017 | 62.10% |
| Jun 30, 2017 | 58.20% |
| Mar 31, 2017 | 80.66% |
| Dec 31, 2016 | 81.04% |
| Sep 30, 2016 | 72.11% |
| Jun 30, 2016 | 72.64% |
| Mar 31, 2016 | 72.16% |
| Dec 31, 2015 | 44.90% |
| Sep 30, 2015 | 43.45% |
| Jun 30, 2015 | 38.91% |
| Mar 31, 2015 | -63.94% |
| Dec 31, 2014 | -57.00% |
| Sep 30, 2014 | -88.78% |
| Jun 30, 2014 | -57.00% |
| Mar 31, 2014 | -84.53% |